“This recognition is a testament to the dedication, experience and expertise of the clinicians, scientists and caregivers at Mission Health,” said Ronald A. Paulus, MD, President and CEO of Mission Health. “We strive every day to provide safe, high quality, compassionate care to each patient, and we are constantly investing in our people, facilities and technology to ensure that every family in western North Carolina can receive the best care possible for generations to come.”
Personalized medicine uses a patient’s genetic profile to make clinical decisions by predicting whether that patient will benefit from a particular medicine or suffer serious side effects. Pharmacogenomics is the study of how variations in an individual’s genes affect the body’s response, not just to cancer drugs but also to other medications.
Lynn Dressler, Dr.P.H, Director of Personalized Medicine and Pharmacogenomics at Mission Health said, “Of the 2,000 drugs on the market, about 170 are known to differ in their effects depending on the patient’s genes.” Dr. Dressler shared an example of a patient who did not get good pain relief after spinal fusion surgery and was hesitant about another surgery until she had pharmacogenomics testing. A better option was found and her pain was greatly reduced after her second procedure.
U.S. News & World Report’s Best Hospitals 2018 Guidebook provides consumers with information needed to make informed decisions and includes articles about cutting-edge health trends and medical advances, like Personalized Medicine.